First Page | Document Content | |
---|---|---|
![]() Date: 2015-06-19 09:17:51Immunology Immunosuppressants Monoclonal antibodies Autoimmune diseases Biotechnology Infliximab Tumor necrosis factor alpha TNF inhibitor Adalimumab Etanercept Monoclonal antibody therapy Ankylosing spondylitis | Add to Reading List |
![]() | BIOLOGICS IN THE PRACTICE OF LAW LINDSAY KELLY* Biologics have come to occupy an increasingly important role in the medical industry, accounting for well over $200 billion in worldwide sales inNot surprisingly, biDocID: 1rrNB - View Document |
![]() | July 15, Bayer Ups Offer to Acquire Monsanto to Approximately $65 Billion Making its first largescale acquisition since becoming a pureplay life sciences company, Bayer has raised its allcDocID: 1qiCw - View Document |
![]() | TABLE OF CONTENTS INTRODUCTION 2DocID: 1qius - View Document |
![]() | RHEUMATOLOGY Rheumatology 2011;50:iv5iv9 doi:rheumatology/ker241 Indirect and mixed treatment comparisons in arthritisDocID: 1pLt5 - View Document |
![]() | JUNE 2016 TABLE OF CONTENTS INTRODUCTIONDocID: 1pshE - View Document |